THERANEXUS: THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON TH

· New milestone for NeuroLead, the active agent screening platform · New publications in scientific journals · Start of Phase I/II clinical trial for Batten disease
Lyon, 28 February 2022 -

Related Keywords

Paris , France General , France , Verlhac , Midi Pyrées , Portejoie , Haute Normandie , French , Anselme Perrier , Nathalie Rouach , Mathieu Charv , Philippe Hantraye , Development Projects For Competitiveness , Bpifrance Structuring Research , Jacob Institute Of Biology , Twitter , Drug Development Technologies , French National Institute Of Health , Atomic Energy Commission , Interdisciplinary Research In Biology , France Center , National Centre For Scientific Research , International Journal Of Molecular Sciences , National Infrastructure In Biology , Molecular Imaging Research Center Mircen , World Rare Disease Day , French Alternative Energies , Bpifrance Rd Innovation Loan , Chief Scientific Officer , Interdisciplinary Research , Jacob Institute , Molecular Imaging Research Center , International Journal , Molecular Sciences , Targeting Neuroglial Interactions , Human Pluripotent Stem Cell , Identify Modulators , Transcription Factor , Structuring Research , Development Projects , Euronext Growth , National Centre , Scientific Research , French National Institute , Medical Research , National Infrastructure , Theranexus , Nveils , Cientific , Advances , Occasion , World , Mare , Disease , 022 ,